The global aortic stents grafts market is on a robust growth trajectory, with projections indicating a substantial increase from USD 2.5 billion in 2023 to an impressive USD 4.2 billion by 2033. This expansion is anticipated to occur at a compound annual growth rate (CAGR) of 5% over the forecast period.
The burgeoning market is primarily driven by a rising incidence of aortic disorders, particularly among the aging population worldwide. As the global demographic continues to shift towards an older age group, the prevalence of aortic conditions is surging, creating a heightened demand for advanced medical solutions.
Aortic stents grafts, essential for treating aortic aneurysms and other related conditions, have become a critical component in the management of these serious health issues. The increasing awareness about aortic disorders, coupled with advancements in medical technology, is further propelling market growth.
Key Factors Driving Market Growth:
- Rising Incidence of Aortic Disorders: The aging population is more susceptible to aortic conditions, leading to greater demand for effective treatment options.
- Technological Advancements: Innovations in aortic stent graft technology are enhancing the effectiveness and safety of treatments, thereby boosting market adoption.
- Growing Awareness: Increased awareness and early diagnosis of aortic disorders are contributing to higher treatment rates and market growth.
As the market continues to expand, stakeholders are optimistic about the potential for new technologies and therapies to further drive growth and improve patient outcomes.
Key Takeaways from the Market Study:
- United Kingdom: The aortic stent grafts market is expected to reach USD 510 million by 2033.
- China: The market is estimated to reach USD 512 million, expanding at a CAGR of 5% through 2033.
- Japan: The market is anticipated to develop significantly, reaching USD 220 million by 2033.
- Germany: The market is expected to experience a 5.1% CAGR through 2033.
“The expanding popularity of testing procedures for early diagnosis of aneurysms, paired with an aging male population, is driving the demand for aortic stent grafts. Since aneurysms, notably AAA, are asymptomatic, early diagnosis can prevent rupture and enable specialists to initiate appropriate treatment,” says FMI’s analyst.
Stay Ahead with Aortic Stents Grafts: Delve into Our Full Report for Extensive Trends and Insights!
Competitive Analysis:
Key players in the aortic stent grafts industry are focusing on technological innovations and strategic collaborations to capitalize on emerging opportunities. Significant participants are investing heavily in research and employing various expansion strategies such as associations, mergers, joint ventures, and innovative advancements.
- Endologix LLC introduced and implanted its ALTO® Abdominal Stent Graft in Canada on May 11, 2021, following the latest authorization from Health Canada.
- TERUMO Aortic announced the PMDA’s authorization for the RelayPro thoracic stent graft system in Japan in March 2022. This contemporary system, designed for treating thoracic aneurysms, features a low profile and caters to patients with limited accessibility.
Key Companies Profiled:
- Cook Medical, Inc.
- W.L. Gore & Associates
- MicroPort Scientific Corporation Inc.
- Medtronic Plc.
- Lombard Medical, Inc.
- Endologix, INC.
- Terumo Corporation Inc.
- Cardinal Health Inc.
- Becton, Dickinson and Company
- Cryolife Inc.
Segmentation Analysis:
- Product Type: Abdominal Aortic Stents Graft, Thoracic Aortic Stents Graft
- End User: Hospitals, Ambulatory Surgical Centers/Outpatient Surgical Centers
- By Region: North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, The Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
